Regenxbio schedules conference call to discuss second-quarter results and operational update

Regenxbio has scheduled a conference call for August 6 at 8:00 a.m. ET to discuss its second-quarter 2026 financial results and provide an operational update. The quarter ended on June 30, 2026. Registration links for the webcast and analyst Q&A are available via the provided references.

Regenxbio schedules an Aug. 6 conference call at 8:00 a.m. ET to review Q2 2026 results, ended June 30, 2026. * Webcast registration: here * Analyst Q&A registration: here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenxbio Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608030705PR_NEWS_USPR_____PH15018) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)